P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors

British Journal of Haematology

Volumn 132, Issue 3, 2006, Pages 359-369

  Brusa, Gianluca ^a,b   Zuffa, Elisa ^a   Mancini, Manuela ^a   Benvenuti, Michela ^a   Calonghi, Natalia ^b   Barbieri, Enza ^b   Santucci, Maria Alessandra ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

BCR ABL; Chronic myeloid leukaemia; Histone deacetylase 1; Histone H4 acetylation; p210 tyrosine kinase

Indexed keywords

BCR ABL PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE H4; PROTEIN TYROSINE KINASE; BCR ABL TYROSINE KINASE; BCR-ABL TYROSINE KINASE; CD34 ANTIGEN; HDAC1 PROTEIN, HUMAN; HISTONE; HISTONE DEACETYLASE;

ACETYLATION; APOPTOSIS; ARTICLE; CELL COMPARTMENTALIZATION; CELL CYCLE PROGRESSION; CELL ISOLATION; CHROMATIN STRUCTURE; CHRONIC MYELOID LEUKEMIA; ENZYME ASSAY; ENZYME REPRESSION; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC STABILITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TRANSCRIPTION INITIATION; CELL LINE; CHEMISTRY; CHROMATIN; CYTOPLASM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; TUMOR CELL LINE;

ACETYLATION; ANTIGENS, CD34; CELL LINE; CELL LINE, TUMOR; CHROMATIN; CYTOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIETIC STEM CELLS; HISTONE DEACETYLASES; HISTONES; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PROTEIN-TYROSINE KINASES;

EID: 33644871736     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05873.x     Document Type: Article

References (76)

1. Angstreich G.R. Matsui W. Huff C.A. Vala M.S. Barber J. Hawkins A.L. Griffin C.A. Smith B.D. Jones R.J. 2005 Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors British Journal of Haematology 130 373 381
2. Bali P. Pranpat M. Bradner J. Balasis M. Fiskus W. Guo F. Rocha K. Kumaraswamy S. Boyapalle S. Atadja P. Seto E. Bhalla K. 2005 Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: A novel basis for antileukaemia activity of histone deacetylase inhibitors Journal of Biological Chemistry 280 26729 26734
3. Beillard E. Pallisgaard N. van der Velden V.H.J. Bi W. Dee R. van der Schoot E. Delabesse E. Macintyre E. Gottardi E. Saglio G. Watzinger F. Lion T. van Dongen J.J.M. Hokland P. Gabert J. 2003 Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)- a Europe against cancer program Leukemia 17 24 74
4. Bhatia R. Holtz M. Niu N. Gray R. Snyder D.S. Sawyers C.L. Arber D.A. Slovak M.L. Forman S.J. 2003 Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment Blood 101 4701 4707
5. Brower-Toland B. Wacker D.A. Fulbright R.M. Lis J.T. Kraus W.L. Wang D.W. 2005 Specific contributions of histone tails and their acetylation to the mechanical stability of nucleosomes Journal of Molecular Biology 346 135 146
6. Campanini F. Santucci M.A. Pattacini L. Brusa G. Piccioli M. Barbieri E. Babini L. Tura S. 2001a Competitive polymerase chain reaction as a method to detect the amplification of bcr-abl gene of chronic myeloid leukemia Haematologica 86 167 173
7. Campanini F. Santucci M.A. Brusa G. Pattacini L. Arpinati M. Rondelli D. Gamberi B. Barbieri E. Babini L. Tura S. 2001b Expression of p21(WAF1/CIP1/SID1) cyclin dependent kinase inhibitor in hematopoietic progenitor cells Gene 273 173 180
8. Carlesso N. Griffin J.D. Druker B.J. 1994 Use of a temperature-sensitive mutant to define the biological effects of the p210 BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line Oncogene 9 149 156
9. Champagne N. Pelletier N. Yang X.J. 2001 The monocytic leukemia zinc finger protein MOZ is a histone acetylatransferase Oncogene 20 404 409
10. Chen J.S. Faller D.V. 2005 Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts Journal of Cellular Physiology 202 87 99
11. Cheong J.W. Chong S.Y. Kim J.Y. Eom J.I. Jeung H.K. Maeng H.Y. Lee S.T. Min Y.H. 2003 Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells Clinical Cancer Research 9 5018 5027
12. Curtin N.J. Campbell P.J. Green A.R. 2005 The Philadelphia translocation and pre-existing myeloproliferative disorders British Journal of Haematology 128 734 736
13. Dion M.F. Altschuler S.J. Wu L.F. Rando O.J. 2005 Genomic characterization reveals a simple histone H4 acetylation code Proceedings of the National Academy of Sciences USA 102 5501 5506
14. Frank S.R. Schroeder M. Fernandez P. Taubert S. Amati B. 2001 Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation Genes Development 15 2069 2082
15. Frank S.R. Parisi T. Taubert S. Fernandez P. Fuchs M Chan H.M. Livingstone D.M. Amati B. 2003 MYC recruits the TIP60 histone acetyltransferase complex to chromatin The European Molecular Biology Organization Journal 4 575 580
16. Galasinski S.C. Louie D.F. Gloor K.K. Resing K.A. Ahn N.G. 2002a q11 Global regulation of post-translational modifications on core histones Journal of Biological Chemistry 277 2579 2588
17. Galasinski S.C. Resing K.A. Goodrich J.A. Ahn N.G. 2002b q12 Phosphatase inhibition leads to histone deacetylase 1 and 2 phosphorylation and disruption of corepressor interactions Journal of Biological Chemistry 277 19618 19626
18. George P. Bali P. Annavarapu S. Scuto A. Fiskus W. Guo F. Sigua C. Sondarva G. Moscinski L. Atadja P. Bhalla K. 2005 Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3 Blood 105 1768 1776
19. Gregoretti I.V. Lee Y.M. Goodson H.V. 2004 Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis Journal of Molecular Biology 338 17 31
20. Grignani F. De Matteis S. Nervi C. Tomassoni L. Gelmetti V. Cioce M. Fanelli M. Ruthardt M. Ferrara F.F. Zamir I. Seiser C. Grignani F. Lazar M.A. Minucci S. Pelicci P.G. 1998 Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukemia Nature 391 815 818
21. WAF1 involves changes in promoter-associated proteins, including HDAC1 Proceedings of the National Academy of Sciences USA 101 141 146
22. Hakansson P. Segal D. Lassen C. Gullberg U. Morse H.C. Fioretos T. Meltzer P.S. 2004 Identification of genes differentially regulated by the P210 BCR/ABL1 fusion oncogene using cDNA microarrays Experimental Hematology 32 476 482
23. Heriche J.K. Chambaz E. 1998 Protein kinase CK2alpha is a target for the Abl and Bcr-Abl kinases Oncogene 17 13 18
24. Hess J.L. 2004 MLL: a histone methyltransferase disrupted in leukemia Trends in Molecular Medicine 10 500 507
25. Huang M. Dorsey J.F. Epling-Burnette P.K. Nimmanapalli R. Landowski T.H. Mora L.B. Niu G. Sinibaldi D. Bai F. Kraker A. Yu H. Moscinski L. Wei S. Djeu J. Dalton W.S. Bhalla K. Loughran T.P. Wu J. Jove R. 2002 Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells Oncogene 21 8804 8816
26. Ibanez V. Sharma A. Buonamici S. Verma A. Kalakonda S. Wang J. Kadkol S. Saunthararajah Y. 2004 AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation Cancer Research 64 4547 4554
27. Insinga A. Monestiroli S. Ronzoni S. Gelmetti V. Marchesi F. Viale A. Altucci L. Nervi C. Minucci S. Pelicci P.L. 2005 Inhibitors of histone deacetylase induce tumor-selective apoptosis through activation of the death receptor pathway Nature Medicine 11 71 76
28. Kaneta Y. Kagami Y. Tsunoda T. Ohno R. Nakamura Y. Katagiri T. 2003 genome-wide analysis of gene expression profiles in chronic myeloid leukemia cells using cDNA microarrays International Journal of Oncology 23 681 691
29. Kawano T. Horiguchi-Yamada J. Iwase S. Akiyama M. Furukawa Y. Kan Y. Yamada H. 2004 Depsipeptide ehnaces imatinib mesylate-induce apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect Anticancer Research 24 2705 2712
30. Kim J.S. Jeung H.K. Cheong J.W. Maeng H. Lee S.T. Hahn J.S. Ko Y.W. Min Y.H. 2004 Apicidin potentiates the imatinib-induced apoptosis of Bcr-Abl-positive human leukemia cells by enhancing the activation of mitochondria-dependent caspase cascades British Journal of Haematology 124 166 178
31. Kronenwett R. Butterweck U. Steidl U. Kliszewski S. Neumann F. Bork S. Diaz Blanco E. Roes N. Graf T. Brors B. Eils R. Maercker C. Kobbe G. Gattermann N. Haas R. 2005 Distinct molecular phenotype of malignant CD34+ hematopoietic stem and progenitor cells in chronic myelogenous leukemia Oncogene 24 5315 5324
32. Kurdistani S.K. Tavazoie S. Grunstein M. 2004 Mapping global histone acetylation patterns to gene expression Cell 117 721 733
33. Lee H. Rezai-Zadeh N. Seto E. 2004 Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A Molecular and Cellular Biology 24 765 773
34. Luger K. Mader A.W. Richmond R.K. Sargent D.F. Richmond T.J. 1997 Crystal structure of the nucleosome core particle at 2·8 A resolution Nature 389 231 233
35. Marley S.B. Lewis J.L. Schneider H. Rudd C.E. Gordon M.Y. 2004 Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitors cells British Journal of Haematology 125 500 511
36. Mazzacurati L. Pattacini L. Brusa G. Mancini M. Benvenuti M. Barbieri E. Martinelli G. Baccarani M. Greenberger J.S. Santucci M.A. 2004 Chk2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571 The Haematology Journal 5 168 177
37. McWhirter J.R. Galasso D.L. Wang J.Y. 1993 A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins Molecular and Cellular Biology 13 7587 7595
38. Minucci S. Maccarana M. Cioce M. De Luca P. Gelmetti V. Segalla S. Di Croce L. Giavara S. Matteucci C. Gobbi A. Bianchini A. Colombo E. Schiavoni I. Badaracco G. Hu X. Lazar M.A. Landsberger N. Nervi C. Pelicci P.G. 2000 Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation Molecular Cell 5 811 820
39. Mukhopadhyay A. Shishodia S. Suttles J. Brittingham K. Lamothe B. Nimmanapalli R. Bhalla K.N. Aggarwal B.B. 2002 Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kB activation and IkB-alpha phosphorylation. Relationship with down-regulation of TNF receptors Journal of Biological Chemistry 277 30622 30628
40. Nagar B. Hantschel O. Young M.A. Scheffzek K. Veach D. Bornmann W. Clarkson B. Superti-Furga G. Kuriyan J. 2003 Structural basis for the autoinhibition of c-Abl tyrosine kinase Cell 112 859 871
41. Nikiforov M.A. Chandriani S. Park J. Kotenko I. Matheos D. Johnsson A. McMahon S.B. Cole M.D. 2002 TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins Molecular and Cellular Biology 22 5054 5063
42. Nimmanapalli R. Fuino L. Bali P. Gasparetto M. Glozak M. Tao J. Moscinski L. Smith C. Wu J. Jove R. Atadja P. Bhalla K. 2003a Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic meylogenous leukemia-blast crisis cells Cancer Research 63 5126 5135
43. Nimmanapalli R. Fuino L. Stobaugh C. Richon V. Bhalla K. 2003b Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells Blood 101 3236 3239
44. Nishioka K. Rice J.C. Sarma K. Erdjument-Bromage H. Werner J. Wang Y. Chuikov S. Venezuela P. Tempst P. Steward R. Lis J.T. Allis C.D. Reinberg D. 2002 PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin Molecular Cell 9 1201 1213
45. Nowicki M.O. Pawlowski P. Fischer T. Hess G. Pawlowski T. Skorski T. 2003 Chronic myelogenous leukemia molecular signature Oncogene 22 3952 3963
46. O'Brien S.G. Guilhot F. Larson R.A. Gathmann I. Baccarani M. Cervantes F. Cornelissen J.J. Fischer T. Hochaus A. Hughes T. Lechner K. Nielsen J.L. Rousselot P. Reiffers J. Saglio G. Shepherd J. Simonsson B. Gratwohl A. Goldman J.M. Kantarjian H. Taylor K. Verhoef G. Bolton A.E. Capdeville R. Druker B.J. IRIS Investigations. 2003 Imatinib compared to interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia New England Journal of Medicine 348 994 1004
47. Kip1 expression Journal of Biological Chemistry 276 23572 23580
48. Peterson C.L. Laniel M.A. 2004 Histones and histone modifications Current Biology 14 546 551
49. Pflum M.K. Tong J.K. Lane W.S. Schreiber S.L. 2001 Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation Journal of Biological Chemistry 276 47733 47741
50. Rahmani M. Reese E. Dai Y. Bauer C. Kramer L.B. Huang M. Jove R. Dent P. Grant S. 2005 Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational change Molecular Pharmacology 67 1166 1176
51. Rayman J.B. Takahashi Y. Indjeian V.B. Dannenberg J.H. Catchpole S. Watson R.J. te Riele H. Dynlacht B.D. 2002 E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex Genes Development 16 933 947
52. Richon V.M. Sandhoff T.W. Rifkind R.A. Marks P.A. 2000 Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation Proceedings of the National Academy of Sciences USA 97 10014 10019
53. Rosato R.P. Maggio S.C. Almerara J.A. Payne S.G. Atadja P. Spiegel S. Dent P. Grant S. 2006 The histone deacetylase inhibitor LAQ-824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide Molecular Pharmacology in press
54. Ruefli A.A. Ausserlechner M.J. Bernhard D. Sutton V.R. Tainton K.M. Kofler R. Smith M.J. Johnstone R.W. 2001 The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species Proceedings of the National Academy of Sciences USA 98 10833 10838
55. Salesse S. Verfaille C.M. 2003 BCR/ABL-mediated increased expression of multiple known and novel genes that may contribute to the pathogenesis of Chronic Myeloid Leukemia Molecular Cancer Therapeutics 2 172 182
56. Sarg B. Helliger W. Talasz H. Koutzamani E. Lindner H.H. 2004 Histone H4 hyperacetylation precludes histone H4 lysine 20 trimethylation Journal of Biological Chemistry 279 53458 53464
57. Seigneurin D. Champelovier P. Mouchiroud G. Berthier R. Leroux D. Prenant M. McGregor J. Starck J. Morle F. Micouin C. 1987 Human chronic myeloid leukemia cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics Experimental Hematology 15 822 832
58. Skorski T. Bellacosa A. Nieborowska-Skorska M. Majewski M. Martinez R. Choi J.K. Trotta R. Wlodarski P. Perrotti D. Chan T.O. Wasik M.A. Tsichlis P.N. Calabretta B. 1997 Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway The European Molecular Biology Organization Journal 16 6151 6161
59. Smith K.M. Yacobi R. van Etten R.A. 2003 Autoinhibition of Bcr-Abl through its SH3 domain Molecular Cell 12 27 37
60. Sokal J.E. Baccarani M. Russo D. Tura S. 1988 Staging and prognosis in chronic myelogenous leukemia Seminars in Hematology 25 49 61
61. Steelman L.S. Pohnert S.C. Shelton J.G. Franklin R.A. Bertrand F.E. McCubrey J.A. 2004 JAK/STAT, Raf/MEK/ERK, PI3K/AKT and BCR/ABL in cell cycle progression and leukemogenesis Leukemia 18 189 218
62. Strahl B.D. Allis C.D. 2000 The language of covalent histone modifications Nature 403 41 45
63. Taplick J. Kurtev V. Kroboth K. Posch M. Lechner T. Seiser C. 2001 Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1 Journal of Molecular Biology 308 27 38
64. Vaisanen S. Dunlop T.W. Frank C. Carlberg C. 2004 Using chromatin immunoprecipitation to monitor 1á,25-dihydroxyvitamin D3-dependent chromatin activity on the human CYP24 promoter Journal of Steroid Biochemistry and Molecular Biology 89-90 277 279
65. Viatour P. Legrand-Poels S. van Lint C. Warnier M. Merville M.P. Gielen J. Piette J. Bours V. Chariot A. 2003 Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3 Journal of Biological Chemistry 278 46541 46548
66. Vinatzer U. Taplick J. Seiser C. Fonatsch C. Wieser R. 2001 The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase British Journal of Haematology 114 566 673
67. Walkey C.R. Fero M.L. Chien W.M. Purton L.E. McArthur G.A. 2005 Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells Nature Cell Biology 7 172 178
68. Wang H. Huang Z.Q. Xia L. Feng Q. Erdjument-Bromage H. Strahl B.D. Briggs S.D. Allis C.D. Wong J. Tempst P. Zhang Y. 2001 Methylation of histone H4 arginine 3 facilitating transcriptional activation by nuclear hormone receptor Proceedings of the National Academy of Sciences USA 293 853 857
69. Xie S. Lin H. Sun T. Arlinghaus R.B. 2002 Jak2 is involved in c-Myc induction by Bcr-Abl Oncogene 21 7137 7146
70. Xu Y. Voelter-Mahlknecht S. Mahlknecht U. 2005 The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines International Journal of Molecular Medicine 15 169 172
71. Yu C. Rahmani M. Almerara J. Subler M. Krystal G. Conrad D. Varticovski L. Dent P. Grant S. 2003a Histone deacetylase inhibitors promote STI571-mediated apoptosis in sensitive and resistant Bcr/Abl+ human myeloid leukemia cells Cancer Research 63 2118 2126
72. Yu C. Rahmani M. Conrad D. Subler M. Dent P. Grant S. 2003b The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571 Blood 102 3756 3774
73. Yu C. Subler M. Rahmani M. Reese E. Krystal C. Conrad D. Dent P. Grant S. 2003c Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathways Cancer Biology & Therapy 2 544 551
74. Zhang J. Xu F. Hashimshony T. Keshet I. Cedar H. 2002 Establishment of transcriptional competence in early and late S phase Nature 420 198 202
75. Zhang X. Ozawa Y. Lee H. Wen Y.D. Tan T.H. Wadzinski B.E. Seto E. 2005 Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/theronine phosphatase 4 Genes & Development 19 827 839
76. Zhu Q.S. Heisterkamp N. Groffen J. 1990 Unique organization of the human BCR gene promoter Nucleic Acids Research 18 7119 7125